PMM2 Antibodies

Santa Cruz Biotechnology provides a broad selection of PMM2 monoclonal antibodies for research focused on understanding PMM2 protein function. PMM2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PMM2, or phosphomannomutase 2, is a crucial enzyme involved in the conversion of mannose-6-phosphate to mannose-1-phosphate, a key step in the synthesis of glycoproteins and glycolipids. Mutations in the PMM2 gene are associated with congenital disorders of glycosylation, highlighting its importance in cellular function and development. Understanding PMM2's role can provide insights into various metabolic pathways and potential therapeutic targets. PMM2 monoclonal antibodies enable precise detection and analysis of PMM2 expression patterns across different tissues and experimental conditions. Researchers can utilize PMM2 monoclonal antibodies to investigate protein-protein interactions and cellular localization patterns. PMM2 monoclonal antibodies support detailed examination of PMM2's involvement in glycosylation pathways and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific understanding of PMM2's role in human health and disease progression.